Cartesian Therapeutics Inc logo

Cartesian Therapeutics Inc

NEW
NAS:RNAC (USA)  
$ 10.71 +0.65 (+6.41%) 11:37 AM EST
At Loss
Market Cap:
$ 324.04M
Enterprise V:
$ 240.28M
Volume:
40.43K
Avg Vol (2M):
167.60K
Trade In:
Volume:
40.43K
At Loss
Avg Vol (2M):
167.60K

Cartesian Therapeutics Inc (RNAC) Dividend

Cartesian Therapeutics Inc (RNAC) does not currently pay a regular dividend. Over the past 3 years it has returned capital to shareholders via buybacks at a rate of -72.1%. View its historical dividend record below and compare with dividend-paying peers.

Frequently Asked Questions: RNAC Dividend

Does Cartesian Therapeutics Inc (RNAC) pay a dividend?

Cartesian Therapeutics Inc (RNAC) does not currently pay a regular dividend. Review the historical record above for any past dividend payments or capital return policies.

Why doesn't Cartesian Therapeutics Inc pay a dividend?

Companies typically forgo dividends to reinvest earnings into growth, R&D, acquisitions, or share buybacks. Cartesian Therapeutics Inc has returned capital to shareholders via buybacks at a rate of -72.1% over the past 3 years.

What are dividend-paying alternatives to Cartesian Therapeutics Inc?

For dividend-paying alternatives in Cartesian Therapeutics Inc's sector, view dividend stocks by industry on GuruFocus's dividend stock screener.